NEWS

Medscape Medical News Headlines

• FDA Approves Risankizumab (Skyrizi) for Psoriatic Arthritis 22 January, 2022
  The approval is the second indication for the anti-interleukin 23 monoclonal antibody after approval for plaque psoriasis was granted in 2019. News Alerts
• Low Vaccine Uptake in Black Communities Often an Access Issue: Study 21 January, 2022
  Data suggest that Black people are equally or more willing than White people to get a vaccine, which may mean access is the bigger problem, researchers say. Medscape Medical News
• Survival Improving in Sports-Related Sudden Cardiac Arrest 21 January, 2022
  Dramatic improvement in survival rates after sports-related sudden cardiac arrests are mainly a result of increased public use of CPR and automated external defibrillators, researchers say. Medscape Medical News
• Long COVID Associated With Risk of Metabolic Liver Disease 21 January, 2022
  Postacute COVID syndrome, an ongoing inflammatory state following infection with SARS-CoV-2, is associated with greater risk of metabolic-associated fatty liver disease. Medscape Medical News
• COVID May Affect Spinal Fluid, Causing 'Brain Fog,' Study Says 21 January, 2022
  Researchers at the University of California, San Francisco, found abnormalities in the cerebrospinal fluid of 10 of 13 people who were infected with SARS-CoV-2 and had thinking problems. WebMD Health News
• 'Post-Truth Era' Complicates COVID-19 Response, Trust in Science 21 January, 2022
  The authors of a fascinating new research study have concluded we are living in a "post-truth era," with baseless beliefs and subjective opinions given a higher priority than verifiable facts. WebMD Health News
• A Prognostic Link Between Dementia and High Cholesterol 21 January, 2022
  Elevated blood markers for neurodegeneration can better predict risk of dementia when markers for cerebrovascular disease are also elevated. A link between vascular health and mental health has been found. First Look
• Omicron Surge Is Undermining Care for Other Health Problems 21 January, 2022
  "A doctor I know pretty well said, 'Roger, we're going to have to improvise right here,' " said Strukhoff, who lives in DeKalb, Illinois. Associated Press
• Texas Judge Blocks Biden Federal Worker Vaccine Mandate 21 January, 2022
  Judge Jeffrey Brown ruled that opponents of Biden's vaccination mandate for federal employees were likely to succeed at trial and blocked the government from enforcing the requirement. Associated Press
• MRI Predicts Response to VEGF Inhibitor in Recurrent Glioblastoma 21 January, 2022
  Predicting the response to therapy comes down to contrast enhancing patterns on the pretreatment MRI, a new study suggests. The study was published as a preprint and has not yet been peer reviewed. First Look
• Decline in CHD Prevalence in US Slowing: New Data 21 January, 2022
  The prevalence of coronary heart disease (CHD) in the US has fallen only by a very small and insignificant amount in the past decade, new data show. Medscape Medical News
• Obesity Hypoventilation Syndrome Ups Risk in DKA Hospitalization 21 January, 2022
  Among US patients hospitalized for diabetic ketoacidosis (DKA), those with obesity hypoventilation syndrome had a higher risk of in-hospital mortality and other adverse outcomes. First Look
• More Than a Month After Launch, iPLEDGE Glitches Persist 21 January, 2022
  The latest improvement attempt is a tool created by the Isotretinoin Products Manufacturers Group (IPMG), the manufacturers responsible for the FDA-mandated REMS program. Medscape Medical News
• Rituximab and COVID Shots: Studies Begin to Answer Key Questions 21 January, 2022
  This article aims to summarize the latest research on how rituximab affects humoral and cell-mediated response after a COVID-19 vaccine primary series, and whether a booster changes patient response. Medscape Medical News
• Two Abstracts About Unapproved Heart Technology Retracted 21 January, 2022
  Both studies involve a technology called pulse field ablation. Medtronic developed one version of the technology, and Farapulse, which is now owned by Boston Scientific, developed another. Retraction Watch